AU2591800A - Synthetic and therapeutic methods for the alpha and beta domains of metallothionein - Google Patents

Synthetic and therapeutic methods for the alpha and beta domains of metallothionein

Info

Publication number
AU2591800A
AU2591800A AU25918/00A AU2591800A AU2591800A AU 2591800 A AU2591800 A AU 2591800A AU 25918/00 A AU25918/00 A AU 25918/00A AU 2591800 A AU2591800 A AU 2591800A AU 2591800 A AU2591800 A AU 2591800A
Authority
AU
Australia
Prior art keywords
metallothionein
alpha
synthetic
therapeutic methods
beta domains
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU25918/00A
Inventor
Bert L. Vallee
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU2591800A publication Critical patent/AU2591800A/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/825Metallothioneins
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/001Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof by chemical synthesis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
AU25918/00A 1998-12-23 1999-12-21 Synthetic and therapeutic methods for the alpha and beta domains of metallothionein Abandoned AU2591800A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US11345998P 1998-12-23 1998-12-23
US60113459 1998-12-23
PCT/US1999/030573 WO2000038654A1 (en) 1998-12-23 1999-12-21 Synthetic and therapeutic methods for the alpha and beta domains of metallothionein

Publications (1)

Publication Number Publication Date
AU2591800A true AU2591800A (en) 2000-07-31

Family

ID=22349564

Family Applications (1)

Application Number Title Priority Date Filing Date
AU25918/00A Abandoned AU2591800A (en) 1998-12-23 1999-12-21 Synthetic and therapeutic methods for the alpha and beta domains of metallothionein

Country Status (2)

Country Link
AU (1) AU2591800A (en)
WO (1) WO2000038654A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2196978B1 (en) * 2001-10-26 2005-03-16 Universitat Autonoma De Barcelona PHARMACEUTICAL COMPOSITION
US7655620B2 (en) * 2005-07-07 2010-02-02 Cancure Laboratories, Llc Use of one or more metal carriers to selectively kill mammalian cells
EP2412727B1 (en) * 2006-02-14 2016-06-29 University Of Tasmania Through The Menzies Research Institute Metallothionein-derived peptide fragments
CN102462687B (en) * 2010-11-12 2013-08-14 上海医药工业研究院 Pharmaceutical composition containing GC-20

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR207116A1 (en) * 1973-03-28 1976-09-15 Ciba Geigy Ag PROCEDURE TO PREPARE NEW DOTRIACONTAPEPTIDOAMIDES
US4732864A (en) * 1983-10-06 1988-03-22 E. I. Du Pont De Nemours And Company Trace-labeled conjugates of metallothionein and target-seeking biologically active molecules
KR100220864B1 (en) * 1993-05-17 1999-09-15 오트리브 데이비스 더블유 Improved detection and therapy of lesions with biotin/avidin-metal chelating protein conjugates

Also Published As

Publication number Publication date
WO2000038654A1 (en) 2000-07-06
WO2000038654B1 (en) 2000-08-17

Similar Documents

Publication Publication Date Title
HUP9904361A3 (en) Use of isobutylgaba and its derivatives for the treatment of pain
IL141403A0 (en) Deleted adenoviruses and methods of making and administering the same
AU1282499A (en) Synthetic fibres for medical use and method of making the same
GB0015235D0 (en) Compositions for the treatment of skin and anorectal conditions
ZA9410078B (en) Methods of inhibiting atrophy of the skin and vagina
CY2508B1 (en) Benzopyrans and their use as therapeutic agents
IL136110A0 (en) Methods and compositions for the treatment of psoriasis
HK1041827B (en) Compounds for the treatment of estrogen-defendent illnesses and methods for making and using the same
AU4774597A (en) Use of 1-hydroxy-2-pyridones for the treatment of skin infections
ZA954984B (en) Compositions and methods for the treatment of tumors
AU6786898A (en) Methods and compositions for the diagnosis and treatment of neuropsychiatric di sorders
AU2591800A (en) Synthetic and therapeutic methods for the alpha and beta domains of metallothionein
AU6786598A (en) Methods and compositions for the diagnosis and treatment of neuropsychiatric di sorders
AU2529799A (en) Benzofuran-4-carboxamides and their therapeutic use
AU2154695A (en) Thioprostaglandins and -prostaglandin-like compounds and therapeutic uses thereof
AU6786798A (en) Methods and compositions for the diagnosis and treatment of neuropsychiatric di sorders
AU8580598A (en) Methods and compositions for the diagnosis and treatment of neuropsychiatric di sorders
EP0754701A4 (en) Novel progesterone compound and use thereof
AU6786698A (en) Methods and compositions for the diagnosis and treatment of neuropsychiatric di sorders
AU1801297A (en) Spiro-ketal derivatives and their use as therapeutic agents
HU9301232D0 (en) Sanitary pad with medical effect
GB9623548D0 (en) The treatment of cold sores
TW298977U (en) Structure of pre-molded template
GB9823939D0 (en) Therapeutic antibody composition and use
GB9823940D0 (en) Therapeutic antibody composition and use

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase